Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis
| Title: | Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis |
|---|---|
| Authors: | Mesa, RubenAff1, IDs41375022016377_cor1; Harrison, ClaireAff2; Oh, Stephen T.Aff3; Gerds, Aaron T.Aff4; Gupta, VikasAff5; Catalano, JohnAff6; Cervantes, FranciscoAff7; Devos, TimothyAff8; Hus, MarekAff9; Kiladjian, Jean-JacquesAff10; Lech-Maranda, EwaAff11; McLornan, DonalAff2; Vannucchi, Alessandro M.Aff12; Platzbecker, UweAff13; Huang, MeiAff14; Strouse, BryanAff14; Klencke, BarbaraAff14; Verstovsek, SrdanAff15 |
| Source: | Leukemia. 36(9):2261-2268 |
| Database: | Springer Nature Journals |